Navigation Links
Rochester Medical Reports Second Quarter Results
Date:5/5/2011

STEWARTVILLE, Minn., May 5, 2011 /PRNewswire/ -- Rochester Medical Corporation (NASDAQ: ROCM) today announced operating results for its second quarter ended March 31, 2011.

The Company reported record sales of $12,853,000 for the current quarter compared to $9,845,000 for the second quarter of last year.  It also reported net loss of ($1,259,000) or ($0.10) per diluted share compared to net loss of ($351,000) or ($0.03) per diluted share for the same quarter of last year.

The approximate 31% increase in sales (29% on constant currency basis) resulted from a 39% increase in Rochester Medical Direct Sales (37% on a constant currency basis) and an 8% increase in Private Label Sales (8% on a constant currency basis). Direct Sales include sales made directly to the end consumer and include all Rochester Medical branded sales, UK Script Easy sales, and all Laprolan sales.  Beginning with the second quarter of this fiscal year, the Company's operating results include the operating results of Laprolan B.V., the Company's newly acquired subsidiary in The Netherlands.   Constant currency basis assumes current exchange rates for all periods in order to exclude the impact of foreign exchange variations.  In the second quarter of fiscal 2011, the U.S. dollar was somewhat weaker versus the pound sterling thus positively affecting Rochester Medical Direct Sales growth levels in actual U.S. dollars given the significant volume of direct sales in the United Kingdom.

Net loss adjusted for certain non-recurring unusual items and certain recurring non-cash expenses, or "Non-GAAP Net Income (Loss)" for the current quarter was ($437,000) or ($.04) per diluted share compared to Non-GAAP Net Income of $140,000 or $.01 per diluted share for the second quarter of last year.  The net loss for the current quarter is attributable to the recent significant increase i
'/>"/>

SOURCE Rochester Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
2. Rochester Medical Completes Acquisition of Laprolan
3. Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation
4. Rochester Medical Reports First Quarter Results and Recent Developments
5. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
6. Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V.
7. Rochester Medical Reports Fourth Quarter and Year-End Results
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
10. Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
11. Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
(Date:12/22/2014)... , Dec. 22, 2014 Cyberonics, Inc. (NASDAQ: ... for the treatment and management of epilepsy, today announced it ... Healthcare Conference on Wednesday, January 14, 2015, in ... Cyberonics, President and Chief Executive Officer, will speak at 11:00 ... can be accessed by clicking on the Investor Relations link ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Insights into the Marketplace and Individual Market Growth 2
(Date:12/26/2014)... 26, 2014 DW-InductionHeating.com (DaWei Induction Heating ... researching and developing, producing and marketing of a series ... business announces their new series of induction brazing ... the company, induction brazing refers to the ... filler material and heat. The manager says that there ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 ... Market Analysis to 2023” focuses on the current ... opportunities in the colorectal cancer market. Stivarga is ... of colon or rectal cancer. Boehringer Ingelheim is ... for the treatment of refractory CRC in the ...
(Date:12/25/2014)... December 26, 2014 Recently, Dylan Queen, ... has excitedly released its collection of discounted prom dresses, ... Percy, a senior spokesman of the company, the promotion ... this promotion is to expand the UK market. , ... several different colors, lengths, and styles: A-line strapless, empire ...
(Date:12/25/2014)... When head lice hits a home or ... to get rid of it while keeping it from taking ... now have the solution right in their neighborhood: Lice ... Troopers provides full spectrum head lice screening and treatment services ... Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... muscular atrophy , , THURSDAY, Jan. 10 (HealthDay News) -- ... pregnant with her second child. Her baby didn,t move, except ... leaving her stomach flat. , Her fears were confirmed ... weak cry, very little muscle tone, he had contractures in ...
... A protein found in human hair shows promise for ... a new treatment option when nerves are cut or crushed ... scientists from Wake Forest University School of Medicine reported that ... up nerve regeneration and improve nerve function compared to current ...
... federal, state levels to combat tobacco use, report says ... registered some significant gains in 2007, with more states ... too little federal and state funding for smoking-prevention and ... taxes. , That,s the conclusion of the American Lung ...
... Supported SelfCare,Inc., a national provider of disease ... awarded Full Disease Management Accreditation from URAC, ... establishes,quality standards for the healthcare industry., ... very seriously. This,national accreditation validates LifeMasters, clinical ...
... efforts through Consumer Innovation ... ... (NYSE:,WLP) is accepting applications for its first Consumer Innovation Event. The,event ... identifying and piloting innovative,programs and services., "The health benefits industry ...
... Jan. 9 Synergy Life Science,Partners, LP, a ... medical device technologies, today announced the successful,completion of ... of $143,million in committed capital. The firm has ... 2006 by John Onopchenko, Richard Stack, M.D., and ...
Cached Medicine News:Health News:Years-Long Search Unlocks Deadly Genetic Disease 2Health News:Years-Long Search Unlocks Deadly Genetic Disease 3Health News:Years-Long Search Unlocks Deadly Genetic Disease 4Health News:Protein in human hair shows promise for regenerating nerves 2Health News:Protein in human hair shows promise for regenerating nerves 3Health News:Smoke-Free Workplace Laws, Cigarette Taxes on the Rise 2Health News:Smoke-Free Workplace Laws, Cigarette Taxes on the Rise 3Health News:Smoke-Free Workplace Laws, Cigarette Taxes on the Rise 4Health News:LifeMasters Receives Full URAC Disease Management Accreditation 2Health News:LifeMasters Receives Full URAC Disease Management Accreditation 3Health News:WellPoint Announces Consumer Innovation Opportunity 2Health News:WellPoint Announces Consumer Innovation Opportunity 3Health News:Synergy Life Science Partners Closes $143M Debut Medical Device Fund 2Health News:Synergy Life Science Partners Closes $143M Debut Medical Device Fund 3
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... The BD Macro-Vue RPR (Rapid Plasma ... Tear-drop Tests are nontreponemal testing procedures ... described in A Manual of Tests ... this manual are the most widely ...
Medicine Products: